Stem cells are unique biological cells defined by two fundamental properties: first, their ability to self-renew by producing at least one daughter cell that retains stem-like characteristics after division, and second, their capacity to differentiate into multiple specialized cell lineages. These dual features make stem cells essential for organismal development, tissue formation, and long-term tissue maintenance throughout life. In the human body, stem cells act as the foundational source for the generation and renewal of diverse cell types—for example, hematopoietic stem cells (HSCs) give rise to blood cells such as erythrocytes, while neural stem cells (NSCs) differentiate into neurons and glial cells.
During embryonic and fetal development, stem cells are distributed across forming tissues and organs, where they persist into adulthood to support ongoing regeneration and repair. Some stem cell populations are transient and exist only during specific developmental stages, while others can be experimentally derived and maintained in vitro. A key example is embryonic stem (ES) cells, which are isolated from early-stage embryos (specifically the inner cell mass) and retain properties similar to primitive ectodermal cells. These ES cells are undifferentiated but pluripotent, meaning they can generate derivatives of all three germ layers and contribute to a wide range of adult tissues under appropriate conditions.
Because of their broad developmental potential, both naturally occurring and laboratory-derived stem cells are central to regenerative medicine research, including gene therapy, cell replacement strategies, and tissue engineering. However, their clinical application remains limited by significant technical challenges, particularly the difficulty of reliably culturing stem cells in vitro while maintaining their self-renewal capacity or directing them efficiently toward specific differentiation pathways.
One of the major obstacles in stem cell bioprocessing is the complexity of stem cell biology itself. Stem cells are often rare within tissues, may divide infrequently, and typically require highly specific microenvironmental conditions to maintain their functional state. As a result, culture systems must be carefully designed to selectively support stem cell populations while accounting for dynamic interactions with differentiating progeny and surrounding cellular environments. In some strategies, enrichment or selection methods are used to increase the proportion of stem cells in culture, improving the efficiency of downstream expansion or differentiation.
Another major limitation lies in the reliance on retrospective functional assays to evaluate stem cell behavior. These assays, while informative, are often time-consuming and complex, which slows the optimization of culture conditions. Furthermore, their interpretation is based on classical models of stem cell behavior that assume irreversible differentiation, progressive lineage restriction, and hierarchical organization from stem cells to committed progenitors. Although these principles have been widely supported, emerging evidence suggests that stem cell behavior may be more flexible than previously thought, highlighting the need to continuously reassess established biological models.
This review (or conceptual framework) focuses on three main aspects: (1) the fundamental biological characteristics of stem cell populations, (2) the engineering challenges involved in designing effective stem cell culture systems, and (3) how recent advances in understanding stem cell regulation can inform improved bioprocess design. While examples are primarily drawn from hematopoietic and embryonic systems, relevant insights from neural and other stem cell populations are also considered to emphasize general principles applicable across tissues.
STEM CELL POPULATIONS IN EMBRYOS AND ADULT TISSUES
Embryonic Stem Cells
Embryonic stem cells (ES cells) are characterized by their ability to proliferate extensively in vitro while maintaining pluripotency, meaning they can contribute to all tissues of the developing organism when reintroduced in vivo. Importantly, they can be genetically manipulated and expanded without losing this developmental potential.
Despite this broad differentiation capacity, ES cells do not contribute to certain extraembryonic structures such as the trophoblast or specific endodermal layers. In vitro, they can be induced to form three-dimensional aggregates (embryoid bodies) containing derivatives of ectoderm, mesoderm, and endoderm. These structures can give rise to a wide range of specialized cell types, including hematopoietic, neuronal, cardiac, and endothelial lineages. Notably, the sequence of differentiation observed in vitro closely resembles normal embryonic development, suggesting that cultured ES cells follow intrinsic developmental programs.
Mouse ES cells were the first to be established and remain a key experimental model, while human ES cells have expanded the relevance of this system for clinical research. Although mouse ES cells can integrate into developing embryos and contribute to chimeras, similar functional validation is more limited in human systems, making their developmental assessment more challenging.
To identify and characterize undifferentiated ES cells, researchers use a combination of surface markers (such as stage-specific embryonic antigens) and transcriptional markers like Oct4. Oct4 plays a central role in maintaining pluripotency, with tightly regulated expression levels controlling cell fate decisions: precise expression maintains self-renewal, moderate increases trigger differentiation, and loss of expression leads to loss of pluripotent identity.
Despite advances in maintaining ES cell cultures, controlling their differentiation in a predictable and efficient manner remains a major challenge. Cytokines and growth factors can influence differentiation outcomes, but often result in heterogeneous cell populations due to complex signaling environments and cell–cell interactions. More recent studies suggest that carefully controlled external signals may enable directed differentiation into specific functional cell types, such as dopaminergic neurons, but these approaches still require further refinement.
A persistent concern is the presence of undifferentiated ES cells within differentiated cultures, which can form teratomas after transplantation. This highlights the need for improved purification strategies, such as selectable genetic systems or lineage-specific promoters, to ensure safety and specificity in therapeutic applications.
TISSUE-SPECIFIC STEM CELLS
Hematopoietic Stem Cells (HSCs)
HSCs are defined by their ability to regenerate the entire blood system following transplantation. Single-cell studies have demonstrated that individual HSCs can give rise to both lymphoid and myeloid lineages and can undergo extensive self-renewal in vivo.
However, despite strong regenerative potential in vivo, achieving sustained expansion of HSCs in vitro remains difficult. While short-term increases in HSC numbers can be achieved using cytokine combinations, long-term expansion is limited by differentiation and environmental constraints. Evidence suggests that the microenvironment plays a critical role in regulating HSC fate, including interactions with stromal cells and secreted regulatory factors.
Functional assays used to study HSCs include colony-forming assays in vitro and transplantation-based assays in vivo. These methods confirm the presence of multipotent progenitors but also highlight the complexity of defining true stem cell populations. Molecular characterization has identified key regulators of hematopoiesis, although a complete understanding of gene regulatory networks remains incomplete.
Neural Stem Cells (NSCs)
Neural stem cells are capable of self-renewal and differentiation into neurons, astrocytes, and oligodendrocytes. They can be isolated from specific regions of the adult brain and expanded in vitro using neurosphere culture systems.
NSCs have demonstrated functional relevance in regeneration studies, including repair of neural damage in disease models. However, their behavior is strongly influenced by growth factors such as EGF, FGF-2, and insulin-like growth factor-1. One limitation is that human NSCs proliferate slowly compared to mouse NSCs, significantly restricting their therapeutic scalability.
Recent findings suggest that signaling pathways, particularly those involving TGF-β family receptors, play a critical role in controlling NSC differentiation. Combinations of signaling molecules can guide lineage specification, although the precise regulatory mechanisms remain under active investigation.
STEM CELL PLASTICITY
Emerging evidence indicates that adult stem cells may possess broader differentiation potential than previously assumed. For example, neural stem cells can contribute to blood formation, and bone marrow-derived cells may generate neural or muscle tissue under certain conditions. These observations challenge traditional views of strict lineage restriction and suggest that stem cell identity may be more context-dependent.
This phenomenon may be explained either by the presence of rare embryonic-like cells in adult tissues or by environmental reprogramming that reveals hidden developmental potential. Understanding these mechanisms is critical for harnessing stem cell plasticity in regenerative medicine.
SELF-RENEWAL AND LINEAGE COMMITMENT
Stem cell fate decisions are governed by a balance between self-renewal and differentiation. A central concept is that these outcomes are influenced by the intensity and duration of signaling through receptor–ligand interactions. When signaling exceeds a certain threshold, self-renewal is favored; when it falls below this threshold, differentiation is triggered.
Key signaling pathways, including JAK/STAT, MAPK, and others, translate extracellular signals into transcriptional responses that determine cell fate. For example, in ES cells, LIF signaling activates STAT3, which is essential for maintaining pluripotency. Similarly, in neuronal systems, the duration of ERK activation determines whether cells proliferate or differentiate.
Gradient-based signaling during development also plays a major role in lineage specification, where different concentrations of morphogens produce distinct cell fates. This indicates that not only signal presence but also signal magnitude and timing are critical determinants of stem cell behavior.
STEM CELL CULTURE AND BIOPROCESS ENGINEERING
A major challenge in stem cell biotechnology is scaling up culture systems from laboratory scale to clinically relevant production volumes. Bioreactor-based systems, particularly stirred suspension cultures, are widely explored due to their scalability and controllability.
These systems allow precise control over environmental parameters such as oxygen concentration, nutrient availability, cytokine levels, and pH. However, they often fail to replicate the complex three-dimensional microenvironments found in vivo, which can influence stem cell behavior.
Dynamic culture conditions, including medium perfusion and removal of inhibitory metabolites, are essential for optimizing stem cell expansion. Mathematical and engineering models suggest that controlling population dynamics and feedback mechanisms can improve yield and maintain stemness.
CONCLUSION
Stem cell bioengineering relies on understanding and controlling the balance between self-renewal, differentiation, and environmental signaling. Current evidence suggests that no single factor can fully direct stem cell fate; instead, outcomes depend on integrated signals including cytokine combinations, receptor dynamics, physicochemical conditions, and microenvironmental context.
Future advances will likely come from combining biological insight with engineering approaches, enabling precise control of stem cell expansion and differentiation. Such progress is essential for translating stem cell biology into effective regenerative therapies and scalable clinical applications.